{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:20:30Z","timestamp":1785514830571,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/eye.2017.73","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T13:03:26Z","timestamp":1493384606000},"page":"1409-1416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye"],"prefix":"10.1038","volume":"31","author":[{"given":"M","family":"Labetoulle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shirlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Leaback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"BFeye201773_CR1","doi-asserted-by":"crossref","unstructured":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. 2007 Ocul Surf 2007; 5: 93\u2013107.","DOI":"10.1016\/S1542-0124(12)70082-4"},{"key":"BFeye201773_CR2","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007; 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"BFeye201773_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"11","author":"C Baudouin","year":"2013","unstructured":"Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013; 11: 246\u2013258.","journal-title":"Ocul Surf"},{"key":"BFeye201773_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovic","year":"2007","unstructured":"Miljanovic B, Dana R, Sullivan DA, Schaumberg DA . Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143: 409\u2013415.","journal-title":"Am J Ophthalmol"},{"key":"BFeye201773_CR5","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1167\/iovs.16-19419","volume":"57","author":"KK Nichols","year":"2016","unstructured":"Nichols KK, Bacharach J, Holland E, Kislan T, Shettle L, Lunacsek O et al. Impact of dry eye disease on work productivity, and patients' satisfaction with over-the-counter dry eye treatments. Invest Ophthalmol Vis Sci 2016; 57: 2975\u20132982.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3 Suppl","key":"BFeye201773_CR6","first-page":"S88","volume":"14","author":"MA Lemp","year":"2008","unstructured":"Lemp MA . Management of dry eye disease. Am J Manag Care 2008; 14 (3 Suppl): S88\u2013101.","journal-title":"Am J Manag Care"},{"key":"BFeye201773_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/bjo.81.7.533","volume":"81","author":"N Yokoi","year":"1997","unstructured":"Yokoi N, Komuro A, Nishida K, Kinoshita S . Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol 1997; 81: 533\u2013536.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201773_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/ICO.0b013e31802e1e04","volume":"26","author":"PA Simmons","year":"2007","unstructured":"Simmons PA, Vehige JG . Clinical performance of a mid-viscosity artificial tear for dry eye treatment. Cornea 2007; 26: 294\u2013302.","journal-title":"Cornea"},{"key":"BFeye201773_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clae.2010.01.007","volume":"33","author":"M Guillon","year":"2010","unstructured":"Guillon M, Maissa C, Ho S . Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage. Cont Lens Anterior Eye 2010; 33: 93\u201399.","journal-title":"Cont Lens Anterior Eye"},{"key":"BFeye201773_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/jop.2013.0050","volume":"30","author":"HJ Oh","year":"2014","unstructured":"Oh HJ, Li Z, Park SH, Yoon KC . Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye. J Ocul Pharmacol Ther 2014; 30: 533\u2013542.","journal-title":"J Ocul Pharmacol Ther"},{"key":"BFeye201773_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5301\/ejo.5000117","volume":"22","author":"C Baudouin","year":"2012","unstructured":"Baudouin C, Cochener B, Pisella PJ, Girard B, Pouliquen P, Cooper H et al. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Eur J Ophthalmol 2012; 22: 751\u2013761.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye201773_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","volume":"27","author":"RM Corrales","year":"2008","unstructured":"Corrales RM, Luo L, Chang EY, Pflugfelder SC . Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells. Cornea 2008; 27: 574\u2013579.","journal-title":"Cornea"},{"key":"BFeye201773_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/02713683.2014.957776","volume":"40","author":"X Hua","year":"2015","unstructured":"Hua X, Su Z, Deng R, Lin J, Li DQ, Pflugfelder SC . Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res 2015; 40: 657\u2013667.","journal-title":"Curr Eye Res"},{"key":"BFeye201773_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/EJO.2010.5730","volume":"21","author":"G Monaco","year":"2011","unstructured":"Monaco G, Cacioppo V, Consonni D, Troiano P . Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy. Eur J Ophthalmol 2011; 21: 243\u2013250.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye201773_CR15","unstructured":"Simmons P, Beard B, Vehige J . Optimizing viscosity of ophthalmic solutions with the combination of two polymers. Presented at: 7th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance; September 18\u201321 2013 Taormina, Sicily, Italy."},{"key":"BFeye201773_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL . Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615\u2013621.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201773_CR17","doi-asserted-by":"crossref","unstructured":"Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 108\u2013152.","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"BFeye201773_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA . Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640\u2013650.","journal-title":"Cornea"},{"key":"BFeye201773_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajo.2009.04.023","volume":"148","author":"JJ Chen","year":"2009","unstructured":"Chen JJ, Rao K, Pflugfelder SC . Corneal epithelial opacity in dysfunctional tear syndrome. Am J Ophthalmol 2009; 148: 376\u2013382.","journal-title":"Am J Ophthalmol"},{"key":"BFeye201773_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jama.295.10.1147","volume":"295","author":"A Le Henanff","year":"2006","unstructured":"Le Henanff A, Giraudeau B, Baron G, Ravaud P . Quality of reporting of noninferiority and equivalence randomized trials. JAMA 2006; 295: 1147\u20131151.","journal-title":"JAMA"},{"key":"BFeye201773_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/IJG.0000000000000506","volume":"25","author":"DB Moore","year":"2016","unstructured":"Moore DB, Hammer JD, Akhtari R, Beck J, Sanders S, Kryscio RJ . Squeeze me if you can: variability in force requirements to extract a drop from common glaucoma bottles. J Glaucoma 2016; 25: 780\u2013784.","journal-title":"J Glaucoma"},{"key":"BFeye201773_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/ICO.0b013e3181e9adcc","volume":"30","author":"JH Lee","year":"2011","unstructured":"Lee JH, Ahn HS, Kim EK, Kim TI . Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 2011; 30: 175\u2013179.","journal-title":"Cornea"},{"key":"BFeye201773_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/ICO.0b013e3181b11648","volume":"29","author":"MA Sanchez","year":"2010","unstructured":"Sanchez MA, Torralbo-Jimenez P, Giron N, de la Heras B, Herrero Vanrell R, Arriola-Villalobos P et al. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study. Cornea 2010; 29: 167\u2013171.","journal-title":"Cornea"},{"key":"BFeye201773_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00417-004-1040-6","volume":"243","author":"F Brignole","year":"2005","unstructured":"Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C . Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol 2005; 243: 531\u2013538.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye201773_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/OPTH.S78184","volume":"9","author":"PA Simmons","year":"2015","unstructured":"Simmons PA, Liu H, Carlisle-Wilcox C, Vehige JG . Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial. Clin Ophthalmol 2015; 9: 665\u2013675.","journal-title":"Clin Ophthalmol"}],"updated-by":[{"DOI":"10.1038\/eye.2017.124","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201773","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/eye.2017.73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/eye201773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:32:50Z","timestamp":1684431170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFeye201773"],"URL":"https:\/\/doi.org\/10.1038\/eye.2017.73","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/eye.2017.124","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ML has served as a consultant for Allergan, Alcon, Bausch and Lomb, MSD, Santen\/Novagali and Th\u00e9a; AS and RL are employees of Allergan plc; CB has served as a consultant for Alcon, Allergan, Santen and Th\u00e9a; and FC declares no conflict of interest. The funding body was involved in the design, data analysis and interpretation, revision of the manuscript for intellectual content, and decision to submit the manuscript for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}